Intellia Therapeutics, Inc. (NTLA) Q4 2025 Earnings Call Transcript [Seeking Alpha]
Intellia Therapeutics, Inc. (NTLA)
Last intellia therapeutics, inc. earnings: 2/27 07:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.intelliatx.com/investor-overview
Company Research
Source: Seeking Alpha
Company Participants Jason Fredette - Vice President of Investor Relations & Corporate Communications John Leonard - President, CEO & Director Edward Dulac - Executive Vice President, Chief Financial Officer and Treasurer Conference Call Participants Maurice Raycroft - Jefferies LLC, Research Division Lili Nsongo - Leerink Partners LLC, Research Division Alec Stranahan - BofA Securities, Research Division Joseph Thome - TD Cowen, Research Division Shelby Hill - RBC Capital Markets, Research Division Jonathan Miller - Evercore ISI Institutional Equities, Research Division Emma Gutstein Mark Aleynick - Goldman Sachs Group, Inc., Research Division Yanan Zhu - Wells Fargo Securities, LLC, Research Division Lut Ming Cheng - JPMorgan Chase & Co, Research Division Silvan Tuerkcan - Citizens JMP Securities, LLC, Research Division Jake Batchelder - William Blair & Company L.L.C., Research Division Terence Flynn - Morgan Stanley, Research Division Michael Ob
Show less
Read more
Impact Snapshot
Event Time:
NTLA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NTLA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NTLA alerts
High impacting Intellia Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
NTLA
News
- Intellia (NTLA) Q4 2025 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Intellia Therapeutics Announces Fourth Quarter and Full-Year 2025 Financial Results and Business Updates [Yahoo! Finance]Yahoo! Finance
- Intellia Therapeutics GAAP EPS of -$0.83 beats by $0.12, revenue of $23.02M beats by $10.85M [Seeking Alpha]Seeking Alpha
- Intellia Therapeutics Announces Fourth Quarter and Full-Year 2025 Financial Results and Business UpdatesGlobeNewswire
- Intellia Therapeutics to Participate in Upcoming Investor ConferencesGlobeNewswire
NTLA
Earnings
- 2/26/26 - Beat
NTLA
Analyst Actions
- 1/28/26 - HC Wainwright
NTLA
Sec Filings
- 2/26/26 - Form S-8
- 2/26/26 - Form 10-K
- 2/26/26 - Form 8-K
- NTLA's page on the SEC website